BR112019003987A2 - formas sólidas de mesilato de cenicriviroc e processos de produção das formas sólidas de mesilato de cenicriviroc - Google Patents
formas sólidas de mesilato de cenicriviroc e processos de produção das formas sólidas de mesilato de cenicrivirocInfo
- Publication number
- BR112019003987A2 BR112019003987A2 BR112019003987A BR112019003987A BR112019003987A2 BR 112019003987 A2 BR112019003987 A2 BR 112019003987A2 BR 112019003987 A BR112019003987 A BR 112019003987A BR 112019003987 A BR112019003987 A BR 112019003987A BR 112019003987 A2 BR112019003987 A2 BR 112019003987A2
- Authority
- BR
- Brazil
- Prior art keywords
- solid forms
- cenicriviroc mesylate
- mesylate solid
- production processes
- cenicriviroc
- Prior art date
Links
- IXPBPUPDRDCRSY-WNRKZQPVSA-N (5e)-8-[4-(2-butoxyethoxy)phenyl]-1-(2-methylpropyl)-n-[4-[(3-propylimidazol-4-yl)methylsulfinyl]phenyl]-3,4-dihydro-2h-1-benzazocine-5-carboxamide;methanesulfonic acid Chemical compound CS(O)(=O)=O.C1=CC(OCCOCCCC)=CC=C1C1=CC=C(N(CC(C)C)CCC\C(=C/2)C(=O)NC=3C=CC(=CC=3)[S+]([O-])CC=3N(C=NC=3)CCC)C\2=C1 IXPBPUPDRDCRSY-WNRKZQPVSA-N 0.000 title abstract 3
- 239000007787 solid Substances 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/04—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing only one sulfo group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662382153P | 2016-08-31 | 2016-08-31 | |
| PCT/US2017/049400 WO2018045043A1 (en) | 2016-08-31 | 2017-08-30 | Solid forms of cenicriviroc mesylate and processes of making solid forms of cenicriviroc mesylate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112019003987A2 true BR112019003987A2 (pt) | 2019-05-28 |
Family
ID=61241572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112019003987A BR112019003987A2 (pt) | 2016-08-31 | 2017-08-30 | formas sólidas de mesilato de cenicriviroc e processos de produção das formas sólidas de mesilato de cenicriviroc |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10301287B2 (enExample) |
| EP (1) | EP3506896A4 (enExample) |
| JP (2) | JP2019526628A (enExample) |
| KR (1) | KR20190057066A (enExample) |
| CN (1) | CN110167550A (enExample) |
| AU (1) | AU2017321594A1 (enExample) |
| BR (1) | BR112019003987A2 (enExample) |
| CA (1) | CA3034606A1 (enExample) |
| MX (1) | MX2019002057A (enExample) |
| RU (1) | RU2019109019A (enExample) |
| SG (1) | SG11201901438VA (enExample) |
| TW (1) | TW201823235A (enExample) |
| WO (1) | WO2018045043A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019238041A1 (zh) * | 2018-06-12 | 2019-12-19 | 南京明德新药研发有限公司 | 一种丙烯酰胺类化合物的晶型及其制备方法 |
| WO2019245518A1 (en) * | 2018-06-18 | 2019-12-26 | Hewlett-Packard Development Company, L.P. | Three-dimensional printing |
| US20210379824A1 (en) * | 2018-06-18 | 2021-12-09 | Hewlett-Packard Development Company, L.P. | Three-dimensional printing |
| US11298876B2 (en) | 2018-06-19 | 2022-04-12 | Hewlett-Packard Development Company, L.P. | Three-dimensional printing |
| US11426931B2 (en) | 2018-06-19 | 2022-08-30 | Hewlett-Packard Development Company, L.P. | Three-dimensional printing |
| US11591486B2 (en) | 2018-06-19 | 2023-02-28 | Hewlett-Packard Development Company, L.P. | Three-dimensional printing |
| CN112638995B (zh) * | 2018-08-31 | 2024-03-19 | 赢创运营有限公司 | 制备聚合物粉末的方法 |
| WO2021133811A1 (en) | 2019-12-26 | 2021-07-01 | Teva Pharmaceuticals International Gmbh | Solid state forms of cenicriviroc and process for preparation thereof |
| CA3179593A1 (en) | 2020-05-22 | 2021-11-25 | Yunfu Luo | Pyridine derivative and application thereof |
| EP4296077B1 (en) * | 2021-02-22 | 2025-05-14 | Asahi Kasei Kabushiki Kaisha | Composition containing cellulose nanofibers |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62265270A (ja) | 1986-05-13 | 1987-11-18 | Zeria Shinyaku Kogyo Kk | 新規イミダゾ−ル誘導体およびそれらを有効成分とする抗潰瘍剤 |
| ATE199721T1 (de) | 1994-07-04 | 2001-03-15 | Takeda Chemical Industries Ltd | Phosphonsäure verbindungen imre herstellung und verwendung |
| CN1282243A (zh) | 1997-12-19 | 2001-01-31 | 武田药品工业株式会社 | 用于拮抗ccr5的含n－酰苯胺衍生物的药物组合物 |
| CA2337307A1 (en) | 1998-08-20 | 2000-03-02 | Osamu Nishimura | Quaternary ammonium salts and their use |
| WO2001017947A1 (en) | 1999-09-06 | 2001-03-15 | Takeda Chemical Industries, Ltd. | Process for the preparation of 2,3-dihydroazepine compounds |
| ATE539062T1 (de) | 2001-08-08 | 2012-01-15 | Tobira Therapeutics Inc | Bizyklishe verbindung, ihre herstellung und verwendung |
| JP2004123694A (ja) * | 2002-03-12 | 2004-04-22 | Takeda Chem Ind Ltd | 光学活性スルホキシド誘導体の製造法 |
| WO2005089714A1 (ja) | 2004-03-24 | 2005-09-29 | Takeda Pharmaceutical Company Limited | エマルション安定化製剤 |
| JP2007269628A (ja) * | 2004-05-28 | 2007-10-18 | Takeda Chem Ind Ltd | 医薬化合物の結晶 |
| GT200600148A (es) | 2005-04-14 | 2006-11-22 | Metodos para el tratamiento y la prevencion de fibrosis | |
| WO2012068366A2 (en) | 2010-11-18 | 2012-05-24 | Yale University | Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus |
| AU2013257951A1 (en) * | 2012-05-11 | 2015-01-22 | Akron Molecules Ag | Use of compounds for the treatment of pain |
| MX383706B (es) | 2013-05-15 | 2025-03-14 | Tobira Therapeutics Inc | Composiciones de cenicriviroc y métodos para elaborarlas y usarlas. |
| BR112016021682A2 (pt) * | 2014-03-21 | 2018-06-26 | Tobira Therapeutics, Inc. | cenicriviroc para o tratamento da fibrose |
| US20170105969A1 (en) * | 2014-06-02 | 2017-04-20 | Tobira Therapeutics, Inc. | Cenicriviroc for the treatment of hiv-2 infection |
| US10526349B2 (en) | 2014-12-23 | 2020-01-07 | Tobira Therapeutics, Inc. | Process of making cenicriviroc and related analogs |
-
2017
- 2017-08-30 JP JP2019531594A patent/JP2019526628A/ja active Pending
- 2017-08-30 MX MX2019002057A patent/MX2019002057A/es unknown
- 2017-08-30 SG SG11201901438VA patent/SG11201901438VA/en unknown
- 2017-08-30 RU RU2019109019A patent/RU2019109019A/ru not_active Application Discontinuation
- 2017-08-30 TW TW106129555A patent/TW201823235A/zh unknown
- 2017-08-30 WO PCT/US2017/049400 patent/WO2018045043A1/en not_active Ceased
- 2017-08-30 CA CA3034606A patent/CA3034606A1/en not_active Abandoned
- 2017-08-30 BR BR112019003987A patent/BR112019003987A2/pt not_active Application Discontinuation
- 2017-08-30 US US15/691,191 patent/US10301287B2/en active Active
- 2017-08-30 CN CN201780061529.6A patent/CN110167550A/zh active Pending
- 2017-08-30 KR KR1020197008786A patent/KR20190057066A/ko not_active Withdrawn
- 2017-08-30 EP EP17847477.1A patent/EP3506896A4/en not_active Withdrawn
- 2017-08-30 AU AU2017321594A patent/AU2017321594A1/en not_active Abandoned
-
2022
- 2022-07-14 JP JP2022113230A patent/JP2022137223A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3034606A1 (en) | 2018-03-08 |
| US20180057481A1 (en) | 2018-03-01 |
| JP2022137223A (ja) | 2022-09-21 |
| SG11201901438VA (en) | 2019-03-28 |
| RU2019109019A3 (enExample) | 2021-08-23 |
| TW201823235A (zh) | 2018-07-01 |
| RU2019109019A (ru) | 2020-10-01 |
| JP2019526628A (ja) | 2019-09-19 |
| WO2018045043A1 (en) | 2018-03-08 |
| EP3506896A4 (en) | 2020-08-26 |
| US10301287B2 (en) | 2019-05-28 |
| EP3506896A1 (en) | 2019-07-10 |
| AU2017321594A1 (en) | 2019-04-18 |
| MX2019002057A (es) | 2019-11-18 |
| KR20190057066A (ko) | 2019-05-27 |
| CN110167550A (zh) | 2019-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112019003987A2 (pt) | formas sólidas de mesilato de cenicriviroc e processos de produção das formas sólidas de mesilato de cenicriviroc | |
| MX2018014154A (es) | Polinucleotidos moduladores. | |
| BR112018001955A2 (pt) | anticorpos monoclonais contra bcma | |
| HUE053737T2 (hu) | Piridopirrolokinoxalin vegyületek, készítményeik és alkalmazásaik | |
| CL2018000039A1 (es) | Derivados de oxopiridina sustituidos | |
| PH12018500894A1 (en) | Aqueous pharmaceutical formulation comprising anti-pd-l1 antibody avelumab | |
| HUE054103T2 (hu) | Izokinolin-3-il-karboxamidok, ezek elõállítása és alkalmazása | |
| MX2019003406A (es) | Estructuras de nonofibra y metodos de uso de las mismas. | |
| MX390014B (es) | Compuestos de dinucleótidos cíclicos y métodos de uso. | |
| MX388350B (es) | Anticuerpos anti-cd166, anticuerpos anti-cd166 activables, y metodos de uso de los mismos. | |
| MX376083B (es) | Formas de dosificacion solidas de palbociclib. | |
| PT3317260T (pt) | Composições de acessulfame de potássio e processos de produção das mesmas | |
| HUE072609T2 (hu) | Fenfluramin-készítmények és elõállítási eljárásaik | |
| MX387402B (es) | Formulaciones eutécticas de clorhidrato de ciclobenzaprina. | |
| MX2020002123A (es) | Sales de ribociclib y formas en estado sólido de las mismas. | |
| ECSP21021189A (es) | Formas de dosificación pediátricas de vitamina d, métodos de elaboración y uso | |
| TR201821116A2 (tr) | POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ | |
| MX389026B (es) | Una composicion farmaceutica y el uso de la misma. | |
| ZA201803476B (en) | Anti-cd22 antibody-maytansine conjugates and methods of use thereof | |
| EA201791716A1 (ru) | Фармацевтический состав | |
| MX2017000862A (es) | Formulacion de factor viii. | |
| BR112018005299A2 (pt) | 1,1-difeniletilenos substituídos com alquenilfenoxi, processos para sua preparação e seu uso | |
| BR112018006560A2 (pt) | composições para higiene bucal e métodos de uso das composições. | |
| MX2017007596A (es) | Procedimiento para fabricar partículas de resinato de fenilefrina; partículas de resinato de fenilefrina; y uso de las partículas de resinato de fenilefrina en formulaciones farmacéuticas. | |
| BR112018006204A2 (pt) | composições para higiene bucal e métodos de uso das composições. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B15V | Prolongation of time limit allowed |
Free format text: TENDO EM VISTA A PORTARIA INPI PR NO 120 DE 16/03/2020, PORTARIA INPI PR NO 161 DE 13/04/2020; PORTARIA INPI PR NO 166 DE 27/04/2020 E PORTARIA INPI PR NO 179 DE 11/05/2020, QUANTO A SUSPENSAO DOS PRAZOS VENCIDOS ENTRE 16/03/2020 A 31/05/2020, DEVOLVE-SE O PRAZO NESSE PEDIDO COM RELACAO A SOLICITACAO DO PEDIDO DE EXAME. |
|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |